Growing community of inventors

Needham, MA, United States of America

Gerald F Cox

Average Co-Inventor Count = 4.09

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 42

Gerald F CoxRobert J Desnick (6 patents)Gerald F CoxEdward Howard Schuchman (6 patents)Gerald F CoxLaura P Andrews (6 patents)Gerald F CoxJames M Murray (6 patents)Gerald F CoxWei-Lien Chuang (3 patents)Gerald F CoxX Kate Zhang (3 patents)Gerald F CoxGerald F Cox (9 patents)Robert J DesnickRobert J Desnick (28 patents)Edward Howard SchuchmanEdward Howard Schuchman (24 patents)Laura P AndrewsLaura P Andrews (6 patents)James M MurrayJames M Murray (6 patents)Wei-Lien ChuangWei-Lien Chuang (5 patents)X Kate ZhangX Kate Zhang (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Genzyme Corporation (9 from 787 patents)

2. Icahn School of Medicine at Mount Sinai (5 from 269 patents)

3. Mount Sinai School of Medicine (1 from 242 patents)


9 patents:

1. 11998592 - Methods of treating acid sphingomyelinase deficiency

2. 10888607 - Marker for acid sphingomyelinase disorders and uses thereof

3. 10188705 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

4. 10022428 - Marker for acid sphingomyelinase disorders and uses thereof

5. 9655954 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

6. 9114139 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

7. 8709408 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

8. 8658162 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

9. 8349319 - Dose escalation enzyme replacement therapy for treating acid sphingomyelinase deficiency

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/8/2025
Loading…